Fresh analysis suggests that patients who stop using popular GLP-1 drugs like semaglutide or tirzepatide tend to recover shed pounds at a significantly accelerated pace than those who halt traditional diet and exercise regimens.
Research printed in a prominent medical journal shows that while obese people often shed a large proportion of their body weight while undergoing treatment, the weight comes back at an estimated rate of 0.8 kg per month once they quit.
"Individuals purchasing such drugs should be cognizant of the danger of rapid weight regain when the treatment concludes," warns researcher Dr. Susan Jebb.
That rate of regain implies a reversion to starting weight in about one and a half years.
Comparing Approaches
The research, which reviewed dozens of studies involving thousands of patients, compared the results of these new drugs with other pills.
Researchers emphasize that people who lose weight through dieting generally see a less rapid weight regain—perhaps 100 grams monthly—post-intervention.
Explaining the Fast Rebound
Nutrition scientists propose the way of the jabs is key to understanding the amplified regain.
The injections mimic a natural hormone called GLP-1, which moderates appetite.
"Long-term administration of GLP-1 concentrations far above than normal could lead to the system to produce less of its endogenous hormone, and could diminish sensitivity to its actions," explained Dr. Adam Collins, a nutrition expert.
"Stopping of this hormone supplement means appetite is unsuppressed, making overeating far more likely."
An Ongoing Issue?
Health authorities recommend the injections for individuals with weight-linked medical conditions, alongside prescribed lifestyle changes.
A number of clinicians argue that, due to the likelihood of weight regain, the treatment is often ongoing.
This perspective is reinforced by pharmaceutical companies, who note that the findings "emphasize the persistent nature of obesity," comparing it to managing diseases like high blood pressure.
Patient Testimonies
People who have discontinued the jabs describe a sudden resurgence of cravings.
"I experienced a switch that goes on and you're instantly ravenous," recalled a patient.
This difficulty is compounded if individuals have not developed lasting lifestyle or habit modifications during therapy.
Growing Adoption
Recent estimates indicate that a significant number of people in the UK have used these injections in the last 12 months, with interest continuing to grow.
- Use is more common among females compared to males.
- The middle-aged demographic shows the greatest level of interest.
- Many access the medications through private prescriptions rather than the NHS.
Finally, researchers emphasize that while these medications are powerful tools for shedding pounds, they are not a permanent fix and maintained weight loss relies on combined lifestyle changes.
